Operating Margin - Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd (SSE:688076) - Alpha Spread
J

Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076

Watchlist Manager
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd
SSE:688076
Watchlist
Price: 68.79 CNY 12.88% Market Closed
Market Cap: 15B CNY
Have any thoughts about
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?
Write Note

Operating Margin
Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd

21.1%
Current
18%
Average
6.8%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.1%
=
Operating Profit
248.7m
/
Revenue
1.2B

Operating Margin Across Competitors

Country CN
Market Cap 14.7B CNY
Operating Margin
21%
Country JP
Market Cap 776 550.9T JPY
Operating Margin
-83%
Country US
Market Cap 843.2B USD
Operating Margin
35%
Country UK
Market Cap 440.4B GBP
Operating Margin
3%
Country DK
Market Cap 3.4T DKK
Operating Margin
45%
Country US
Market Cap 385.8B USD
Operating Margin
29%
Country US
Market Cap 278.3B USD
Operating Margin
29%
Country UK
Market Cap 240.2B USD
Operating Margin
21%
Country CH
Market Cap 206.1B CHF
Operating Margin
32%
Country CH
Market Cap 191.2B CHF
Operating Margin
29%
Country US
Market Cap 162B USD
Operating Margin
19%

Profitability Report

View the profitability report to see the full profitability analysis for Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
21.1%
=
Operating Profit
248.7m
/
Revenue
1.2B
What is the Operating Margin of Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd?

Based on Jiangsu Sinopep Allsino Biopharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 21.1%.